Microsoft Appoints New Responsible Tech Lead to Humanize Rapid AI Development
Market Update ZBH BUD and VTRS Show Mixed Trends Amid Sector Rotation
Podcast Hall of Fame Inductees Signal Industrys Strategic Direction A Financial Perspective
Berkshire Hathaways Latest Filing May Reveal Warren Buffetts Tiny Purchase Teased to CNBC
JPMorgans Summer Reading List for Wealthy Clients Highlights AI Leadership and Business Lessons from Lemons
Venezuelan Prisoner Protests and Security Response Spark Political Tensions
Ashland Inc ASH Q1 2026 Earnings EPS Misses Estimates Stock Gains Slightly
CB Q1 2026 Earnings Solid EPS Beat Amid Premium Growth and Underwriting Discipline
AVGO Q1 2026 Earnings EPS Miss and Tepid Stock Response Amid Mixed Signals
Builders FirstSource BLDR Q1 2026 Earnings EPS Falls Short Amid Persistent Housing Headwinds
RCMT Q1 2026 Earnings EPS Misses Estimates by Over 26
OCUL Q1 2026 Earnings WiderthanExpected Loss but Stock Gains on Pipeline Progress
ReNew Energy Global Warrant RNWWW Stalls at Pennies Whats Next for the Speculative Security
Meridian Holdings MRDN Falls 35 as Stock Tests Support Near 944
Biglari Holdings BH Declines 27 as It Approaches Key Support Near 262
Manhattan Associates MANH Edges Higher Near Key Resistance as Supply Chain Tech Momentum Holds
Rave Restaurant Group RAVE Slips 24 as Price Tests Support Near 275
Grupo Financiero Galicia GGAL Surges 54 Argentine Bank Breaks Higher on Volume
Select Medical Holdings SEM Holds Steady Near Support Testing Key Resistance Zone
OR Royalties Inc OR Shows Gains Amid Positive Momentum Key Levels to Watch
Great Lakes Dredge Dock Corporation GLDD Consolidates at 1700 as Market Awaits Catalyst
Great Elm Capital Corp Notes GECCI Inch Higher to 2545 Stability in a FixedIncome Landscape
Nu Skin Enterprises NUS Rebounds 37 as It Tests Key Resistance Zone
How Dwindling Diesel Prices Could Offer Unexpected Summer Savings for Drivers
Agios Pharmaceuticals Q1 2026 Earnings Narrowed Loss Beats Expectations Stock Rises 6
Propanc Biopharma PPCB Edges Lower Amid Biotech Volatility